3 Post-Earning Outlooks for Top Movers: Costco Wholesale Corporation (COST), iRobot Corporation (IRBT), BioScrip Inc. (BIOS)

Page 1 of 2

Costco Wholesale Corporation (COST)Earnings can dictate the direction of a stock for the following three months. Investors pay close attention to earnings and often make emotional decisions based on the performance of a stock post-earnings. However, the performance of a stock following earnings should never be the first line of research, rather the last. With that being said, I am looking at three companies that reported earnings on Monday and providing my outlook, regardless of stock performance.

Not a Spectacular Quarter, But Still the Best in the Space

Shares of retailer Costco Wholesale Corporation (NASDAQ:COST) came close to touching new highs on Monday, increasing 1.29% following an earnings report that met expectations. The company saw top-line growth of 8% year-over-year (yoy), which was fueled by a 15% rise in membership fees. More importantly, this rise was due to volume, not a price hike. Looking ahead, the company continues to see strong performance in same-store sales, and so far, has fared well against Amazon.com, Inc. (NASDAQ:AMZN)’s Prime membership.

Personally, I wasn’t too impressed with Costco’s quarter, but I think what impressed the Street is that the company did not see the same struggles experienced by Target Corporation (NYSE:TGT) or Wal-Mart Stores, Inc. (NYSE:WMT) in the quarter. With that being said, I was very impressed with its 39% rise in net profit, despite a $62 million tax benefit. This is a company with a lot of room to grow, trading with operating margins of just 2.82%. Therefore, with it being cheaper on a price/sales basis than either Target or Wal-Mart, and seeing greater growth, I think COST is a “buy” and is the best of the three.

Strong Growth Under-Performing Stock that is a ‘Buy’

BioScrip Inc. (NASDAQ:BIOS) saw a 12.57% rise on Monday, touching new highs, after an earnings report that beat expectations. First, the company saw top line growth of 14.2% and posted sales of $180.7 million, $6.83 million better than the consensus. Then, it posted an EPS of $0.04, which was $0.03 better than analysts expected. Furthermore, the company’s full-year revenue guidance between $830 million and $865 million trumped the consensus of $770 million.

BioScrip Inc. (NASDAQ:BIOS) has seen a 76% rise over the last year, however after this quarter, the stock is being added to my Motley Fool “CAPS” list the minute I am done with this paragraph. It is a stock with double-digit growth that continues to trade with a price/sales far below 1.0. It is a small under-the-radar company that often gets forgotten in the discussion of best small cap stocks. But in my opinion, this is a good investment for the next year to come; it’s simply too cheap compared to growth and that distinction will create value for shareholders.

Page 1 of 2
blog comments powered by Disqus
Insider Monkey Headlines
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 44 percentage points in 21 months Learn how!

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!